Expression of Concern: Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Practices and Patient Outcomes · Health and Medical Research Impacts · Health Systems, Economic Evaluations, Quality of Life
Following publication of this article [1] concerns have been raised regarding the process by which participant data was collected for use in the study and the extent of informed consent granted by participants during the data collection process by the Australian Department of Veterans’ Affairs.
The JMIR Editorial Office will investigate these issues in accordance with journal policies on ethical approval and by adhering to Committee on Publication Ethics (COPE) guidelines in seeking to resolve the matter.
In the interim, the JMIR Editorial Office issues this Expression of Concern. Further information will be provided in due course.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Andrade AQ Calabretto JP Pratt NL et al Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial J Med Internet Res 01102022241 e 33873 doi 10.2196/33873 Medline 35006086 PMC 8787661 · doi ↗ · pubmed ↗